Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine

被引:157
作者
Burk, O
Tegude, H
Koch, I
Hustert, E
Wolbold, R
Glaeser, H
Klein, K
Fromm, MF
Nuessler, AK
Neuhaus, P
Zanger, UM
Eichelbaum, M
Wojnowski, L
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Tubingen, Div Pharmacol, D-72076 Tubingen, Germany
[3] Humboldt Univ, Charite, Dept Surg, D-13353 Berlin, Germany
[4] Epidauros Biotechnol AG, D-82347 Bernried, Germany
关键词
D O I
10.1074/jbc.M202345200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human CYP3A enzymes play a pivotal role in the metabolism of many drugs, and the variability of their expression among individuals may have a strong impact on the efficacy of drug treatment. However, the individual contributions of the four CYP3A genes to total CYP3A activity remain unclear. To elucidate the role of CYP3A7, we have studied its expression in human liver and intestine. In both organs, expression of CYP3A7 mRNA was polymorphic. The recently identified CYP3A7*1C allele was a consistent marker of increased CYP3A7 expression both in liver and intestine, whereas the CYP3A7*1B allele was associated with increased CYP3A7 expression only in liver. Because of the replacement of part of the CYP3A7 promoter by the corresponding region of CYP3A4, the CYP3A7*1C allele contains the proximal ER6 motif of CYP3A4. The pregnane X and constitutively activated receptors were shown to bind with higher affinity to CYP3A4-ER6 than to CYP3A7-ER6 motifs and transactivated only promoter constructs containing CYP3A4-ER6. Furthermore, we identified mutations in CYP3A7*1C in addition to the ER6 motif that were necessary only for activation by the constitutively activated receptor. We conclude that the presence of the ER6 motif of CYP3A4 mediates the high expression of CYP3A7 in subjects carrying CYP3A7*1C.
引用
收藏
页码:24280 / 24288
页数:9
相关论文
共 39 条
  • [1] Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7
    Bertilsson, G
    Berkenstam, A
    Blomquist, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) : 139 - 144
  • [2] Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325
  • [3] Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
    Geick, A
    Eichelbaum, M
    Burk, O
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 14581 - 14587
  • [4] Genomic organization of the human CYP3A locus:: identification of a new, inducible CYP3A gene
    Gellner, K
    Eiselt, R
    Hustert, E
    Arnold, H
    Koch, I
    Haberl, M
    Deglmann, CJ
    Burk, O
    Buntefuss, D
    Escher, S
    Bishop, C
    Koebe, HG
    Brinkmann, U
    Klenk, HP
    Kleine, K
    Meyer, UA
    Wojnowski, L
    [J]. PHARMACOGENETICS, 2001, 11 (02): : 111 - 121
  • [5] Expression of cytochrome P450 3A7 in Escherichia coli: Effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase
    Gillam, EMJ
    Wunsch, RM
    Ueng, YF
    Shimada, T
    Reilly, PEB
    Kamataki, T
    Guengerich, FP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 346 (01) : 81 - 90
  • [6] The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
    Goodwin, B
    Hodgson, E
    Liddle, C
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1329 - 1339
  • [7] The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture
    Greuet, J
    Pichard, L
    Bonfils, C
    Domergue, J
    Maurel, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) : 689 - 694
  • [8] Cytochrome P-450 3A4: Regulation and role in drug metabolism
    Guengrich, FP
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 1 - 17
  • [9] GENE STRUCTURE OF CYP3A4, AN ADULT-SPECIFIC FORM OF CYTOCHROME-P450 IN HUMAN LIVERS, AND ITS TRANSCRIPTIONAL CONTROL
    HASHIMOTO, H
    TOIDE, K
    KITAMURA, R
    FUJITA, M
    TAGAWA, S
    ITOH, S
    KAMATAKI, T
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02): : 585 - 595
  • [10] The genetic determinants of the CYP3A5 polymorphism
    Hustert, E
    Haberl, M
    Burk, O
    Wolbold, R
    He, YQ
    Klein, K
    Nuessler, AC
    Neuhaus, P
    Klattig, J
    Eiselt, R
    Koch, I
    Zibat, A
    Brockmöller, J
    Halpert, JR
    Zanger, UM
    Wojnowski, L
    [J]. PHARMACOGENETICS, 2001, 11 (09): : 773 - 779